Clinical Trial
doi: 10.1159/000225424.
An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer
- PMID: 7360486
- DOI: 10.1159/000225424
Item in Clipboard
Clinical Trial
An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer
Oncology.
1980.
Abstract
A phase II study utilizing VP-16 and adriamycin in a randomized fashion tested the concept of synchronization of the drugs in treatment of metastatic breast cancer. Although there was a trend in median survival following the synchronized schedule, there was no significant difference in survival or progression-free intervals. The concept of synchronization was not established.
Similar articles
-
Evaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancer.Oncology. 1976;33(3):146-8. doi: 10.1159/000225129. Oncology. 1976. PMID: 1012648 Clinical Trial.
-
VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lung.Tumori. 1979 Feb 28;65(1):105-9. doi: 10.1177/030089167906500112. Tumori. 1979. PMID: 442215
-
Doxorubicin plus VP-16-213 for the treatment of refractory breast carcinoma.Am J Clin Oncol. 1982 Oct;5(5):515-9. Am J Clin Oncol. 1982. PMID: 6758569 Clinical Trial.
-
Podophyllotoxin derivative VP 16-213.Cancer Chemother Pharmacol. 1979;3(2):71-80. doi: 10.1007/BF00254976. Cancer Chemother Pharmacol. 1979. PMID: 389478 Review.
-
Etoposide (VP-16-213).Cancer Treat Rev. 1979 Jun;6(2):107-24. doi: 10.1016/s0305-7372(79)80045-6. Cancer Treat Rev. 1979. PMID: 385138 Review. No abstract available.
Cited by
-
Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.Drugs. 1990 Mar;39(3):438-90. doi: 10.2165/00003495-199039030-00008. Drugs. 1990. PMID: 2184009 Review. No abstract available.
-
Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy.Cochrane Database Syst Rev. 2016 Mar 3;3(3):CD005008. doi: 10.1002/14651858.CD005008.pub4. Cochrane Database Syst Rev. 2016. PMID: 26938118 Free PMC article.
-
Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen.Cancer Chemother Pharmacol. 1982;7(2-3):231-3. doi: 10.1007/BF00254557. Cancer Chemother Pharmacol. 1982. PMID: 6896298 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
